ORGANIC
LETTERS
2007
Vol. 9, No. 5
765-767
A Cascade Reaction Consisting of
Pictet Spengler-Type Cyclization and
−
Smiles Rearrangement: Application to
the Synthesis of Novel Pyrrole-Fused
Dihydropteridines
Jinbao Xiang, Lianyou Zheng, Feng Chen, Qun Dang, and Xu Bai*
The Center for Combinatorial Chemistry and Drug DiscoVery, Jilin UniVersity,
75 Haiwai Street, Changchun, Jilin 130012, P. R. China
Received December 4, 2006
ABSTRACT
Tandem Pictet
The reaction of 4-chloro-5-pyrrol-1-ylpyrimidine amino aldehyde with an amine under an acidic condition yielded the Pictet
cyclization product diazepine, which readily underwent Smiles rearrangement to give a novel pyrrolo[1,2-f]pteridine derivative.
−
Spengler-type cyclization and Smiles rearrangement have been discovered in the synthesis of pyrimidine-fused heterocycles.
−Spengler-type
Pyrimidine moiety, as a structural component of several key
biomolecules, has been widely employed in the design of
biologically active agents. Its fused bicyclic analogues,
pteridines, have also been reported to exhibit a variety of
biological activities and constitute the backbones of several
marketed drugs. For example, methotrexate (MTX) is used
as an antitumor agent and triamterene as a diuretic. In
addition, some pteridine derivatives exhibit potent inhibitory
activity against biological targets such as dihydrofolate
reductase,1 adenosine kinase,2 neuronal nitric oxide synthase,3
cAMP-specific phosphodiesterase,4 mycobacterial FtsZ,5 and
hepatitis C virus NS5B RNA-dependent RNA polymerase.6
Although there are a few examples of pteridine scaffolds,
few reports exist describing the synthesis of pyrrolo[1,2-f]-
pteridines.7
As a part of our ongoing interest in novel pyrimidine-
fused heterocycles,7b,8 we sought efficient methodologies to
construct novel fused heterocyles. Tandem reactions are
efficient strategies in organic synthesis, since they enable
(4) Merz, K. H.; Marko, D.; Regiert, T.; Reiss, G.; Frank, W.; Eisenbrand,
G. J. Med. Chem. 1998, 41, 4733.
(5) Reynolds, R. C.; Srivastava, S.; Ross, L. J.; Suling, W. J.; White, E.
L. Bioorg. Med. Chem. Lett. 2004, 14, 3161.
(6) Ding, Y.; Girardet, J.; Smith, K. L.; Larson, G.; Prigaro, B.; Lai, V.
C. H.; Zhong, W.; Wu, J. Z. Bioorg. Med. Chem Lett. 2005, 15, 675.
(7) (a) Nishimura, N.; Hasegawa, Y.; Mizuno, S.; Yuasa, M.; Maeba, I.
Heterocycles 1998, 48, 2339. (b) Zheng, L.; Dang, Q.; Guo, S.; Xiang, J.;
Bai, X. Chem. J. Chinese UniV. 2006, 27, 1869.
(8) (a) Yang, J.; Dang, Q.; Liu, J.; Wei, Z.; Wu, J.; Bai, X. J. Comb.
Chem. 2005, 7, 474. (b) Liu, J.; Dang, Q.; Wei, Z.; Zhang, H.; Bai, X. J.
Comb. Chem. 2005, 7, 627. (c) Yang, J.; Che, X.; Dang, Q.; Wei, Z.; Bai,
X. Org. Lett. 2005, 7, 1541. (d) Fu, R.; Xu, X.; Dang, Q.; Bai, X. J. Org.
Chem. 2005, 70, 10810. (e) Che, X.; Zheng, L.; Dang, Q.; Bai, X.
Tetrahedron 2006, 62, 2563. (f) Zheng, L.; Xiang, J.; Dang, Q.; Guo, S.;
Bai, X. J. Comb. Chem. 2005, 7, 813. (g) Zheng, L.; Xiang, J.; Dang, Q.;
Guo, S.; Bai, X. J. Comb. Chem. 2006, 8, 381. (h) Liu, J.; Dang, Q.; Wei,
Z.; Shi, F.; Bai, X. J. Comb. Chem. 2006, 8, 410. (i) Fu, R.; Xu, X.; Dang,
Q.; Chen, F.; Bai, X. Org. Lett. 2007, 9, 571-574.
(1) (a) Taylor, E. C.; Berrier, J. V.; Cocuzza, A. J.; Kobylecki, R.;
McCormack, J. J. J. Med. Chem. 1977, 20, 1215. (b) Rosowsky, A.; Cody,
V.; Galitsky, N.; Fu, H.; Papoulis, A. T.; Queener, S. F. J. Med. Chem.
1999, 42, 4853.
(2) Gomtsyan, A.; Didomenico, S.; Lee, C. H.; Stewart, A. O.; Bhagwat,
S. S.; Kowaluk, E. A.; Jarvis, M. F. Bioorg. Med. Chem. Lett. 2004, 14,
4165.
(3) (a) Fro¨hlich, L. G.; Kotsonis, P.; Traub, H.; Taghavi-Moghadam, S.;
Al-Masoudi, N.; Hofmann, H.; Strobel, H.; Matter, H.; Pfleiderer, W.;
Schmidt, H. H. H. W. J. Med. Chem. 1999, 42, 4108. (b) Matter, H.;
Kotsonis, P.; Klingler, O.; Strobel, H.; Fro¨hlich, L. G.; Frey, A.; Pfleiderer,
W.; Schmidt, H. H. H. W. J. Med. Chem. 2002, 45, 2923.
10.1021/ol0629364 CCC: $37.00
© 2007 American Chemical Society
Published on Web 02/06/2007